Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Leukemia | Research article

Validity and reliability of the EQ-5D-5 L in family caregivers of leukemia patients

Authors: Limin Li, Chaojie Liu, Xiuzhi Cai, Hongjuan Yu, Xueyun Zeng, Mingjie Sui, Erwei Zheng, Yang Li, Jiao Xu, Jin Zhou, Weidong Huang

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Purpose

This study aimed to test the validity and reliability of the five-level EuroQol five-dimensional (EQ-5D-5 L) instrument in family caregivers (FCs) of leukemia patients in Heilongjiang of China.

Methods

A cross-sectional survey was conducted on 298 family caregivers (FCs) of leukemia patients from three major cancer centers in the capital city of Heilongjiang province of China. Their dimensional scores of the EQ-5D-5 L were compared with those of the WHOQOL-BREF to test the convergent validity (constructs measuring the same concept) and divergent validity (constructs measuring different concepts) of the EQ-5D-5 L. Repeated surveys were conducted on 271 participants to determine the test–retest reliability of the EQ-5D-5 L.

Results

The four physical dimensions (mobility, self-care, usual activities, and pain/discomfort) of the EQ-5D-5 L had moderate or high correlations with the physical health domain of the WHOQOL-BREF, with a correlation coefficient (r) ranging from 0.459 to 0.559. The anxiety/depression dimension of the EQ-5D-5 L had a high correlation (r = 0.667) with the psychological domain of the WHOQOL-BREF. By contrast, lower but still significant physical-to-psychological correlations were found between the two instruments (r ranging from 0.219 to 0.396). In addition, the EQ-5D-5 L dimensional scores showed no or weak correlations with the environment and social domains of the WHOQOL-BREF (r ranging from 0.016 to 0.207). High test-retest reliability (> 0.7) was evident.

Conclusion

The Chinese version of the EQ-5D-5 L has satisfactory reliability and validity in FCs of leukemia patients. It can be used to elicit utility of health-related quality of life in FCs of leukemia.
Literature
1.
go back to reference Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.CrossRef Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.CrossRef
3.
go back to reference Stewart B, Wild CP: World cancer report 2014. 2014. Stewart B, Wild CP: World cancer report 2014. 2014.
4.
go back to reference Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.CrossRef Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.CrossRef
5.
go back to reference Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555–67.CrossRef Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555–67.CrossRef
6.
go back to reference Global R. National life expectancy. All-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544.CrossRef Global R. National life expectancy. All-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544.CrossRef
7.
go back to reference Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602.CrossRef Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602.CrossRef
8.
go back to reference Cohen SA, Cook S, Kelley L, Sando T, Bell AE. Psychosocial factors of caregiver burden in child caregivers: results from the new national study of caregiving. Health Qual Life Outcomes. 2015;13(1):120.CrossRef Cohen SA, Cook S, Kelley L, Sando T, Bell AE. Psychosocial factors of caregiver burden in child caregivers: results from the new national study of caregiving. Health Qual Life Outcomes. 2015;13(1):120.CrossRef
9.
go back to reference Yu H, Li L, Liu C, Huang W, Zhou J, Fu W, Ma Y, Li S, Chang Y, Liu G. Factors associated with the quality of life of family caregivers for leukemia patients in China. Health Qual Life Outcomes. 2017;15(1):55.CrossRef Yu H, Li L, Liu C, Huang W, Zhou J, Fu W, Ma Y, Li S, Chang Y, Liu G. Factors associated with the quality of life of family caregivers for leukemia patients in China. Health Qual Life Outcomes. 2017;15(1):55.CrossRef
10.
go back to reference Yamazaki S, Sokejima S, Mizoue T, Eboshida A, Fukuhara S. Health-related quality of life of mothers of children with leukemia in Japan. Qual Life Res. 2005;14(4):1079–85.CrossRef Yamazaki S, Sokejima S, Mizoue T, Eboshida A, Fukuhara S. Health-related quality of life of mothers of children with leukemia in Japan. Qual Life Res. 2005;14(4):1079–85.CrossRef
11.
go back to reference Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2(3):169–80.CrossRef Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2(3):169–80.CrossRef
12.
go back to reference Johnson JA, Coons SJ. Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res. 1998;7(2):155–66.CrossRef Johnson JA, Coons SJ. Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res. 1998;7(2):155–66.CrossRef
13.
14.
go back to reference Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ, Siebert U, Sullivan SD. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24(3):244–58.CrossRef Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ, Siebert U, Sullivan SD. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24(3):244–58.CrossRef
16.
go back to reference Wu A, Jacobson D, Frick K, Clark R, Revicki D, Freedberg K, Scott-Lennox J, Feinberg J. Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res. 2002;11(3):273–82.CrossRef Wu A, Jacobson D, Frick K, Clark R, Revicki D, Freedberg K, Scott-Lennox J, Feinberg J. Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res. 2002;11(3):273–82.CrossRef
17.
go back to reference Kaarlola A, Pettilä V, Kekki P. Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients. Intensive Care Med. 2004;30(12):2245–52.CrossRef Kaarlola A, Pettilä V, Kekki P. Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients. Intensive Care Med. 2004;30(12):2245–52.CrossRef
18.
go back to reference Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43(7):736–49.CrossRef Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43(7):736–49.CrossRef
19.
go back to reference Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20(4):662–9.CrossRef Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20(4):662–9.CrossRef
20.
go back to reference Fang J. Reliability and validity for Chinese version of WHO quality of life scale. Chin Psychol Health. 1999;4:203–5. Fang J. Reliability and validity for Chinese version of WHO quality of life scale. Chin Psychol Health. 1999;4:203–5.
21.
go back to reference Skevington SM, Lotfy M, O'Connell K. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13(2):299–310.CrossRef Skevington SM, Lotfy M, O'Connell K. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13(2):299–310.CrossRef
22.
go back to reference Yu H, Zhang H, Yang J, Liu C, Lu C, Yang H, Huang W, Zhou J, Fu W, Shi L. Health utility scores of family caregivers for leukemia patients measured by EQ-5D-3L: a cross-sectional survey in China. BMC Cancer. 2018;18(1):950.CrossRef Yu H, Zhang H, Yang J, Liu C, Lu C, Yang H, Huang W, Zhou J, Fu W, Shi L. Health utility scores of family caregivers for leukemia patients measured by EQ-5D-3L: a cross-sectional survey in China. BMC Cancer. 2018;18(1):950.CrossRef
23.
go back to reference Khanna R, Jariwala K, Bentley JP. Psychometric properties of the EuroQol five dimensional questionnaire (EQ-5D-3L) in caregivers of autistic children. Qual Life Res. 2013;22(10):2909–20.CrossRef Khanna R, Jariwala K, Bentley JP. Psychometric properties of the EuroQol five dimensional questionnaire (EQ-5D-3L) in caregivers of autistic children. Qual Life Res. 2013;22(10):2909–20.CrossRef
24.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mcfadden ET, Carbone PP. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–56.CrossRef Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mcfadden ET, Carbone PP. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–56.CrossRef
25.
go back to reference Pattanaphesaj J, Thavorncharoensap M. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes. 2015;13(1):14.CrossRef Pattanaphesaj J, Thavorncharoensap M. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes. 2015;13(1):14.CrossRef
26.
go back to reference Deniz H, Inci F. The burden of care and quality of life of caregivers of leukemia and lymphoma patients following peripheric stem cell transplantation. J Psychosoc Oncol. 2015;33(3):250–62.CrossRef Deniz H, Inci F. The burden of care and quality of life of caregivers of leukemia and lymphoma patients following peripheric stem cell transplantation. J Psychosoc Oncol. 2015;33(3):250–62.CrossRef
27.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. biometrics. 1977;33(1):159–74.PubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. biometrics. 1977;33(1):159–74.PubMed
28.
go back to reference Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420.CrossRef Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420.CrossRef
29.
go back to reference Cohen J. Statistical power analysis for the behavioral sciences (2nd Edition). Routledge: Lawrence Erlbaum Associates; 2013.CrossRef Cohen J. Statistical power analysis for the behavioral sciences (2nd Edition). Routledge: Lawrence Erlbaum Associates; 2013.CrossRef
30.
go back to reference Fang H, Farooq U, Wang D, Yu F, Younus MI, Guo X. Reliability and validity of the EQ-5D-3L for Kashin–Beck disease in China. SpringerPlus. 2016;5(1):1924.CrossRef Fang H, Farooq U, Wang D, Yu F, Younus MI, Guo X. Reliability and validity of the EQ-5D-3L for Kashin–Beck disease in China. SpringerPlus. 2016;5(1):1924.CrossRef
31.
go back to reference Xing Y, Ma A. Study on reliability and validity of Chinese version of EQ-5D-5L. Shanghai Med Pharmaceutical J. 2013;34:40–3. Xing Y, Ma A. Study on reliability and validity of Chinese version of EQ-5D-5L. Shanghai Med Pharmaceutical J. 2013;34:40–3.
32.
go back to reference Koh D, bin Abdullah AMK, Wang P, Lin N, Luo N. Validation of Brunei’s Malay EQ-5D questionnaire in patients with type 2 diabetes. PLoS One. 2016;11(11):e0165555.CrossRef Koh D, bin Abdullah AMK, Wang P, Lin N, Luo N. Validation of Brunei’s Malay EQ-5D questionnaire in patients with type 2 diabetes. PLoS One. 2016;11(11):e0165555.CrossRef
33.
go back to reference Tran BX, Ohinmaa A, Nguyen LT. Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health Qual Life Outcomes. 2012;10(1):132.CrossRef Tran BX, Ohinmaa A, Nguyen LT. Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health Qual Life Outcomes. 2012;10(1):132.CrossRef
34.
go back to reference Kim TH, Jo M-W, Lee S-i, Kim SH, Chung SM. Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res. 2013;22(8):2245–53.CrossRef Kim TH, Jo M-W, Lee S-i, Kim SH, Chung SM. Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res. 2013;22(8):2245–53.CrossRef
35.
go back to reference Jia Y, Cui F, Li L, Zhang D, Zhang G, Wang F, Gong X, Zheng H, Wu Z, Miao N. Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Qual Life Res. 2014;23(8):2355–63.CrossRef Jia Y, Cui F, Li L, Zhang D, Zhang G, Wang F, Gong X, Zheng H, Wu Z, Miao N. Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Qual Life Res. 2014;23(8):2355–63.CrossRef
36.
go back to reference Cheung PWH, Wong CKH, Samartzis D, Luk KDK, Lam CLK, Cheung KMC, Cheung JPY. Psychometric validation of the EuroQoL 5-dimension 5-level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis Spinal Disord. 2016;11(1):19.CrossRef Cheung PWH, Wong CKH, Samartzis D, Luk KDK, Lam CLK, Cheung KMC, Cheung JPY. Psychometric validation of the EuroQoL 5-dimension 5-level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis Spinal Disord. 2016;11(1):19.CrossRef
37.
go back to reference Tilford JM, Grosse SD, Robbins JM, Pyne JM, Cleves MA, Hobbs CA. Health state preference scores of children with spina bifida and their caregivers. Qual Life Res. 2005;14(4):1087–98.CrossRef Tilford JM, Grosse SD, Robbins JM, Pyne JM, Cleves MA, Hobbs CA. Health state preference scores of children with spina bifida and their caregivers. Qual Life Res. 2005;14(4):1087–98.CrossRef
38.
go back to reference Bell CM, Araki SS, Neumann PJ. The association between caregiver burden and caregiver health-related quality of life in Alzheimer disease. Alzheimer Dis Assoc Disord. 2001;15(3):129–36.CrossRef Bell CM, Araki SS, Neumann PJ. The association between caregiver burden and caregiver health-related quality of life in Alzheimer disease. Alzheimer Dis Assoc Disord. 2001;15(3):129–36.CrossRef
Metadata
Title
Validity and reliability of the EQ-5D-5 L in family caregivers of leukemia patients
Authors
Limin Li
Chaojie Liu
Xiuzhi Cai
Hongjuan Yu
Xueyun Zeng
Mingjie Sui
Erwei Zheng
Yang Li
Jiao Xu
Jin Zhou
Weidong Huang
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Leukemia
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5721-2

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine